blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0300784

EP0300784 - Peptides [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.07.1994
Database last updated on 15.06.2024
Most recent event   Tooltip11.07.2008Change - representativepublished on 13.08.2008  [2008/33]
Applicant(s)For all designated states
BTG INTERNATIONAL LIMITED
101 Newington Causeway
London SE1 6BU / GB
[N/P]
Former [1992/36]For all designated states
BRITISH TECHNOLOGY GROUP LIMITED
101 Newington Causeway
London SE1 6BU / GB
Former [1989/04]For all designated states
NATIONAL RESEARCH DEVELOPMENT CORPORATION
101 Newington Causeway
London SE1 6BU / GB
Inventor(s)01 / Galpin, Ian James
Deceased / GB
[1989/04]
Representative(s)Wallace, Sheila Jane, et al
Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[N/P]
Former [2008/33]Wallace, Sheila Jane, et al
Marks & Clerk 90 Long Acre
London WC2E 9RA / GB
Former [1994/08]Wallace, Sheila Jane, et al
Patents Department British Technology Group Limited 101 Newington Causeway
GB-London SE1 6BU / GB
Former [1993/35]Eyles, Winifred Joyce, Dr.
Patents Department British Technology Group Ltd 101 Newington Causeway
London SE1 6BU / GB
Former [1992/36]Stephenson, Gerald Frederick
Patents Department British Technology Ltd 101 Newington Causeway
London SE1 6BU / GB
Former [1989/04]Stephenson, Gerald Frederick
Patents Department British Technology Ltd 101 Newington Causeway
London SE1 6BU / GB
Application number, filing date88306696.121.07.1988
[1989/04]
Priority number, dateGB1987001729922.07.1987         Original published format: GB 8717299
[1989/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0300784
Date:25.01.1989
Language:EN
[1989/04]
Type: A3 Search report 
No.:EP0300784
Date:13.06.1990
Language:EN
[1990/24]
Type: B1 Patent specification 
No.:EP0300784
Date:01.09.1993
Language:EN
[1993/35]
Search report(s)(Supplementary) European search report - dispatched on:EP25.04.1990
ClassificationIPC:C07K7/06, A61K37/02
[1989/04]
CPC:
C07K7/06 (EP,US); A61P29/00 (EP); A61P31/04 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61K38/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   IT,   LI,   LU,   NL,   SE [1993/23]
Former [1989/04]AT,  BE,  CH,  DE,  FR,  GB,  IT,  LI,  LU,  NL,  SE 
TitleGerman:Peptide[1989/04]
English:Peptides[1989/04]
French:Peptides[1989/04]
Examination procedure14.04.1989Examination requested  [1989/26]
19.12.1991Despatch of a communication from the examining division (Time limit: M04)
18.03.1992Reply to a communication from the examining division
12.08.1992Despatch of a communication from the examining division (Time limit: M06)
11.01.1993Reply to a communication from the examining division
09.02.1993Despatch of communication of intention to grant (Approval: Yes)
03.03.1993Communication of intention to grant the patent
24.05.1993Fee for grant paid
24.05.1993Fee for publishing/printing paid
Opposition(s)02.06.1994No opposition filed within time limit [1994/34]
Fees paidRenewal fee
07.06.1990Renewal fee patent year 03
04.06.1991Renewal fee patent year 04
05.06.1992Renewal fee patent year 05
11.06.1993Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]  - JOURNAL OF MEDICINAL CHEMISTRY, vol. 29, no. 6, 1986, pages 978-984, Washington, DC, US; D.H. RICH et al.: "Synthesis and antimitogenic activities of four analogues of cyclosporin A modified in the 1-position"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.